Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.
Lin CK, Lin WL, Chen FL, Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, Han CP. Lin CK, et al. Among authors: chen fl. Int J Gynecol Pathol. 2011 Jul;30(4):372-9. doi: 10.1097/PGP.0b013e31820c9ff3. Int J Gynecol Pathol. 2011. PMID: 21623202
Anti-cytokeratin CAM5.2 (BD Biosciences) and CK8 give no remarkable advantages to the pancytokeratin cocktail of antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in detecting disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.
Lin WL, Chen FL, Han CP. Lin WL, et al. Among authors: chen fl. Ann Surg Oncol. 2011 Dec;18 Suppl 3:S261-2; author reply S263-4. doi: 10.1245/s10434-010-1419-z. Epub 2010 Dec 2. Ann Surg Oncol. 2011. PMID: 21125337 No abstract available.
Cytokeratin 8/18 monoclonal antibody is dissimilar to anti-cytokeratin CAM 5.2 reagent--Comment on: "Oral metastatic hepatocellular carcinoma: A changing demographic in Europe and North America. Immunohistochemical advances in the microscopic diagnosis. Oral Oncol. 2010 Aug 20 [Epub ahead of print]".
Wang PH, Chen FL, Lin WL, Tyan YS, Han CP. Wang PH, et al. Among authors: chen fl. Oral Oncol. 2011 Aug;47(8):775. doi: 10.1016/j.oraloncology.2010.08.012. Epub 2010 Oct 16. Oral Oncol. 2011. PMID: 20952246 No abstract available.
Source of anti-cytokeratin CAM 5.2 reagent.
Lin WL, Chen FL, Lee MY, Han CP. Lin WL, et al. Among authors: chen fl. Int J Surg Pathol. 2011 Jun;19(3):409-10; author reply 410. doi: 10.1177/1066896911406729. Int J Surg Pathol. 2011. PMID: 21665861 No abstract available.
Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2.--a comment on: "Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation, Experimental and Molecular Pathology 90(2): 194-200, April 2011".
Lin WL, Chen FL, Kuo JF, Lee MY, Han CP. Lin WL, et al. Among authors: chen fl. Exp Mol Pathol. 2011 Aug;91(1):323-4. doi: 10.1016/j.yexmp.2011.04.001. Epub 2011 Apr 13. Exp Mol Pathol. 2011. PMID: 21510931 No abstract available.
Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2. Comment on: "A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010; 65(6): 1009-1021".
Wang SC, Chen FL, Lin WL, Wang PH, Han CP. Wang SC, et al. Among authors: chen fl. Cancer Chemother Pharmacol. 2011 Jan;67(1):243-4; author reply 245. doi: 10.1007/s00280-010-1490-y. Epub 2010 Dec 14. Cancer Chemother Pharmacol. 2011. PMID: 21153823 No abstract available.
354 results